Abiopharma

🔍 Bell Blake R (Executive)

Company: EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 2,907 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | shares_owned_after: 60,182.86 | transaction_form_type: 4
• Acquired 105 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | shares_owned_after: 60,287.43 | transaction_form_type: 4
• Sold 1,115 shares of Common Stock at $147.89 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: false | shares_owned_after: 59,172.43 | transaction_form_type: 4
• Acquired 0 shares of Restricted Stock Units ("RSUs") (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: false | shares_owned_after: 2,907.43 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 2,907 shares of Restricted Stock Units ("RSUs") (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 105 shares of Dividend Equivalent Rights - 2023 RSUs (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Each RSU and DER represent a contingent right to receive the economic equivalent of one common shares of the issuer. The RSUs and DERs vested on May 1, 2026.